insights_auto
Why is INO up 24.28%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.51
arrow_upward
+24.28%(+0.29) 1D
$1.54
arrow_upward
+1.98% (+0.030)bedtimeAfter hours
Closed: Nov 9, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.30
High
$1.60
Low
$1.26
Mkt. cap
155.49M
Avg. vol.
17.42M
Volume
31.11M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.30
High
$1.60
Low
$1.26
Mkt. cap
155.49M
Avg. vol.
17.42M
Volume
31.11M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Investing.com UK
·
9 hours ago
Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
Quantisnow
·
9 hours ago
INO: Inovio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a...
TradingView
·
10 hours ago
INO Q3'26 Earnings: EPS estimate is (0.20) USD
Investing.com
·
3 days ago
Inovio stock tumbles 25% on $75M share offering
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com